Prescription drug · ANDA
Labetalol Hydrochloride NDC 58657-908
Labetalol 300 mg/1 · Tablet, Film coated · Oral · Method Pharmaceuticals, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 58657-908-01 | 5865709080158657090801 | 100 BLISTER PACK in 1 CARTON (58657-908-01) / 1 TABLET, FILM COATED in 1 BLISTER PACK (58657-908-10)Marketed from Jul 1, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Labetalol Hydrochloride
- Generic name (nonproprietary)
- labetalol hydrochloride
- Active ingredients
- Labetalol — 300 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- Method Pharmaceuticals, LLCNDC labeler code 58657
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 075215
- Marketing start
- Listing expires
- Other FDA classes
- Adrenergic beta-Antagonists (Mechanism)
- Identifiers
- Product ID 58657-908_46b55541-52d5-7213-e063-6294a90affc4SPL ID 46b55541-52d5-7213-e063-6294a90affc4SPL set ID 733d6e32-ac90-4796-bf25-9d5887c897a5RxCUI 896758, 896762, 896766UNII R5H8897N95UPC 0358657603014, 0358657603502, 0358657602505, 0358657604509, 0358657602017, 0358657604011
- Pharmacologic class
- beta-Adrenergic Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N458657090801followed by a unit qualifier and the quantityPackage 58657-0908-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Labetalol Hydrochloride is indicated in the management of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including beta adrenergic blockers. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than one drug to achieve blood pressure goa…
Excerpt only. Read the full label for complete information.
About NDC 58657-908
- What is NDC 58657-908?
- 58657-908 is the product NDC for Labetalol Hydrochloride, Labetalol 300 mg/1 tablet, film coated, listed with the FDA by Method Pharmaceuticals, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Labetalol Hydrochloride.
- What is the active ingredient?
- Labetalol.
- Who is the labeler?
- Method Pharmaceuticals, LLC, NDC labeler code 58657. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Labetalol Hydrochloride?
- 137 other product NDCs are listed under this name. See all Labetalol Hydrochloride NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Labetalol Hydrochloride products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Labetalol Hydrochloride | Labetalol hydrochloride 200 mg/1 | TabletOral | Coupler LLC | 67046-1697 | 67046-1697-03 |
| Labetalol Hydrochloride | Labetalol hydrochloride 100 mg/20mL | Injection, SolutionIntravenous | Armas Pharmaceuticals Inc. | 72485-515 | 72485-0515-01 |
| Labetalol Hydrochloride | Labetalol hydrochloride 100 mg/1 | TabletOral | Coupler LLC | 67046-1693 | 67046-1693-03 |
| Labetalol Hydrochloride | Labetalol hydrochloride 300 mg/1 | TabletOral | BluePoint Laboratories | 68001-702 | 68001-0702-0068001-0702-03 |
| Labetalol Hydrochloride | Labetalol hydrochloride 400 mg/1 | TabletOral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-726 | 23155-0726-0123155-0726-05 |
| Labetalol Hydrochloride | Labetalol hydrochloride 200 mg/1 | TabletOral | NorthStar Rx LLC | 72603-903 | 72603-0903-0172603-0903-02 |
| Labetalol Hydrochloride | Labetalol hydrochloride 100 mg/1 | TabletOral | NorthStar Rx LLC | 72603-902 | 72603-0902-0172603-0902-02 |
| Labetalol Hydrochloride | Labetalol hydrochloride 300 mg/1 | TabletOral | NorthStar Rx LLC | 72603-904 | 72603-0904-0172603-0904-02 |
| Labetalol Hydrochloride | Labetalol hydrochloride 100 mg/1 | TabletOral | BluePoint Laboratories | 68001-700 | 68001-0700-0068001-0700-03 |
| Labetalol Hydrochloride | Labetalol hydrochloride 200 mg/1 | TabletOral | BluePoint Laboratories | 68001-701 | 68001-0701-0068001-0701-03 |
Other NDCs under ANDA 075215
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Labetalol Hydrochloride | Labetalol 100 mg/1 | Tablet, Film coatedOral | REMEDYREPACK INC. | 70518-4201 |
| Labetalol Hydrochloride | Labetalol 300 mg/1 | Tablet, Film coatedOral | Bryant Ranch Prepack | 71335-9690 |
| Labetalol Hydrochloridelabetalol | Labetalol 100 mg/1 | Tablet, Film coatedOral | Marlex Pharmaceuticals Inc | 10135-711 |
| Labetalol Hydrochloridelabetalol | Labetalol 200 mg/1 | Tablet, Film coatedOral | Marlex Pharmaceuticals Inc | 10135-712 |
| Labetalol Hydrochloridelabetalol | Labetalol 300 mg/1 | Tablet, Film coatedOral | Marlex Pharmaceuticals Inc | 10135-713 |
| Labetalol Hydrochloride | Labetalol 200 mg/1 | Tablet, Film coatedOral | Bryant Ranch Prepack | 72162-1676 |
| Labetalol Hydrochloride | Labetalol 100 mg/1 | Tablet, Film coatedOral | Bryant Ranch Prepack | 72162-1675 |
| Labetalol Hydrochloride | Labetalol 300 mg/1 | Tablet, Film coatedOral | Bryant Ranch Prepack | 72162-1677 |
| Labetalol Hydrochloride | Labetalol hydrochloride 300 mg/1 | Tablet, Film coatedOral | A-S Medication Solutions | 50090-6833 |
| Labetalol Hydrochloride | Labetalol 300 mg/1 | Tablet, Film coatedOral | Method Pharmaceuticals, LLC | 58657-604 |
| Labetalol Hydrochloride | Labetalol 100 mg/1 | Tablet, Film coatedOral | Method Pharmaceuticals, LLC | 58657-602 |
| Labetalol Hydrochloride | Labetalol 100 mg/1 | Tablet, Film coatedOral | Bryant Ranch Prepack | 71335-3065 |
| Labetalol Hydrochloride | Labetalol 200 mg/1 | Tablet, Film coatedOral | Method Pharmaceuticals, LLC | 58657-603 |
| Labetalol Hydrochloride | Labetalol 100 mg/1 | Tablet, Film coatedOral | Bryant Ranch Prepack | 63629-1162 |
| Labetalol Hydrochloride | Labetalol 100 mg/1 | Tablet, Film coatedOral | Bryant Ranch Prepack | 63629-1161 |
| Labetalol Hydrochloride | Labetalol 300 mg/1 | Tablet, Film coatedOral | Bryant Ranch Prepack | 63629-1166 |
| Labetalol Hydrochloride | Labetalol 200 mg/1 | Tablet, Film coatedOral | Bryant Ranch Prepack | 63629-1163 |
| Labetalol Hydrochloride | Labetalol 200 mg/1 | Tablet, Film coatedOral | Bryant Ranch Prepack | 63629-1164 |
| Labetalol Hydrochloride | Labetalol 300 mg/1 | Tablet, Film coatedOral | Bryant Ranch Prepack | 63629-1165 |
| Labetalol Hydrochloride | Labetalol 200 mg/1 | Tablet, Film coatedOral | Bryant Ranch Prepack | 71335-2057 |
Showing 20 of 27.